What are the recommended guidelines for diagnosing and managing polycystic ovary syndrome (PCOS) in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Guidelines for Diagnosing and Managing PCOS

Use the Rotterdam criteria for diagnosis in adults: presence of any two of the following—hyperandrogenism (clinical or biochemical), ovulatory dysfunction, or polycystic ovaries—after excluding other androgen-excess disorders. 1, 2, 3

Diagnostic Criteria

Adults

  • Require 2 of 3 features: 2, 3, 4

    • Hyperandrogenism (clinical signs like hirsutism/acne OR elevated androgens)
    • Ovulatory dysfunction (irregular menstrual cycles)
    • Polycystic ovarian morphology on ultrasound OR elevated anti-Müllerian hormone (AMH) levels 2, 3
  • Key refinement: AMH can now substitute for pelvic ultrasound in adults only, simplifying diagnosis and avoiding invasive imaging in some cases 2, 3

Adolescents

  • Diagnosis requires BOTH: 5

    • Irregular menstrual cycles (defined by time postmenarche)
    • Clinical or biochemical hyperandrogenism
  • Critical caveat: Do NOT use polycystic ovarian morphology on ultrasound or AMH levels for diagnosis in adolescents—these are normal developmental findings in this age group 5

  • Adolescents with only one feature are considered "at risk" and require symptom management plus ongoing monitoring 5

Exclusion Testing

  • Rule out other causes of androgen excess: congenital adrenal hyperplasia, Cushing syndrome, androgen-secreting tumors, thyroid dysfunction, and hyperprolactinemia 4, 6

First-Line Management: Lifestyle Intervention

Initiate multicomponent lifestyle programs combining diet, exercise, and behavioral strategies for ALL women with PCOS regardless of weight, before or concurrent with any medication. 1

Exercise Prescription

  • Weight maintenance: ≥150 minutes/week moderate-intensity OR ≥75 minutes/week vigorous activity, plus resistance training twice weekly 1
  • Weight loss: ≥300 minutes/week moderate-intensity OR ≥150 minutes/week vigorous activity 1
  • Target heart rate during aerobic sessions: 70–90% of age-predicted maximum (220 minus age) 1

Dietary Approach

  • Emphasize low-glycemic-index foods, high fiber, omega-3 fatty acids, Mediterranean-style patterns, and anti-inflammatory foods—no single diet is superior 1, 7
  • Reduce sugar-sweetened beverages and fruit juices 1
  • Focus on portion-size control 1

Weight Management Rationale

  • Women with PCOS gain weight faster than unaffected peers, with acceleration beginning in adolescence 1
  • Even 5–10% weight loss improves reproductive function, metabolic parameters, and psychological wellbeing 1
  • Obesity worsens all PCOS manifestations including insulin resistance, hyperandrogenism, and psychological comorbidities 1
  • Monitor body weight and waist circumference regularly 1

Pharmacologic Management

For Menstrual Irregularity and Hyperandrogenism (Non-Fertility Goals)

Combined oral contraceptive pills (COCPs) are first-line pharmacologic therapy for regulating menstrual cycles and treating hirsutism/acne in women not seeking pregnancy. 1, 4

  • COCPs provide endometrial protection against hyperplasia/cancer risk from chronic anovulation 1
  • In adolescents, use low-dose preparations 5

For Metabolic Features

  • Metformin improves metabolic/glycemic abnormalities and menstrual irregularities 6, 5
  • Metformin has limited or no benefit for hirsutism, acne, or infertility 6
  • Consider metformin in adolescents for metabolic features and cycle regulation 5

For Infertility

  • Clomiphene remains first-line therapy for ovulation induction 6
  • The 2023 guideline emphasizes cheaper and safer fertility management approaches 3

Medications with Unfavorable Risk-Benefit

  • Thiazolidinediones have an unfavorable risk-benefit ratio overall 6
  • Statins require further study 6

Comprehensive Screening and Long-Term Management

Psychological Health

Systematically screen all women with PCOS for depression, anxiety, eating disorders, body-image concerns, and low self-esteem. 1

  • Address weight stigma sensitively during clinical encounters 1
  • Mental health disorders are highly prevalent and may be linked to gut dysbiosis 8

Metabolic and Cardiovascular Screening

  • Screen for risk factors for diabetes, cardiovascular disease, and metabolic syndrome 3, 4
  • PCOS is now recognized as a cardiovascular disease risk-enhancing factor with elevated risk of myocardial infarction and stroke even during reproductive years 8
  • Evaluate for obstructive sleep apnea 3

Endometrial Protection

  • Assess risk factors for endometrial cancer, particularly in women with chronic anovulation 4, 6

Pregnancy Considerations

  • Women with PCOS have high risk of adverse pregnancy outcomes requiring appropriate counseling and monitoring 3

Special Populations

Postmenopausal Women

  • No consistent PCOS phenotype exists in postmenopausal women, making diagnosis problematic 6
  • Focus on managing established metabolic and cardiovascular comorbidities 3

Transition Planning for Adolescents

  • Establish lifelong health planning including healthy lifestyles, metabolic screening, and transition to adult care 5
  • Use shared decision-making throughout management 5

Common Pitfalls to Avoid

  • Do not use ultrasound or AMH for diagnosis in adolescents—these lead to overdiagnosis 5
  • Do not delay lifestyle intervention while initiating medications—they should be concurrent 1
  • Do not overlook psychological screening—depression and anxiety are as important as metabolic features 1, 3
  • Do not minimize the importance of weight stigma—explain health risks while avoiding stigmatizing language 1, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.